M Bergmann

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

A. Berrebi, H. Döhner, G. Fingerle-Rowson, 2010, The Lancet.